Evaluating Safety and Effectiveness of Supraglottic Oxygenation via Nasotracheal Intubation During Deep Sedation for Fiberoptic Bronchoscopy to Reduce Hypoxia

What this Trial Is About

Researchers are studying a new way to deliver oxygen during deep sedation for fiberoptic bronchoscopy, a procedure used to diagnose and treat lung conditions like hypoxia, pulmonary nodules, and infections. The study focuses on improving patient comfort and safety by testing a modified oxygen delivery method using a wire-reinforced nasotracheal tube. This device aims to reduce the risk of low oxygen levels during the procedure, which is common due to airway obstruction and stress responses. Participants in the study receive supraglottic oxygen therapy through a thin, wire-reinforced endotracheal tube inserted through the nose. This tube connects easily to an oxygen supply and helps keep the airway open, allowing better oxygen flow during sedation. The study evaluates how well this method works and how safe it is for patients during bronchoscopy. During the procedure, researchers monitor oxygen levels closely to detect hypoxia or respiratory depression. They measure the incidence of low oxygen saturation, including severe cases, throughout the bronchoscopy. Participants safety and response to the oxygen delivery method are assessed, and the study collects detailed data on oxygen levels during sedation. The trial runs until March 2026 and involves ongoing observation of the procedures effects on breathing and oxygenation.

The Efficacy and Safety of the Supraglottic Oxygenation Via Nasotracheal Intubation for Deep Sedation Fiberoptic Bronchoscopy